Referanslar

1. Kim JA, Jang J-H, Lee S-Y. An Updated Comprehensive Review on Vitamin A and Carotenoids in Breast Cancer: Mechanisms, Genetics, Assessment, Current Evidence, and Future Clinical Implications. Nutrients. 2021;13(9):3162 [Crossref]  [PubMed]
2. D'Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: an update. Nutrients 2011; 3:63e103. [Crossref]  [PubMed]
3. Connolly RM, Nguyen NK, Sukumar S. Molecular path-ways: Current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin. Cancer Res. 2013; 9:1651-1659. [Crossref]  [PubMed]
4. Han X, Zhao R, Wang Y, Ma H, Yu M, Chen X, et al. Di- etary vitamin A intake and circulating vitamin A concentra- tions and the risk of three common cancers in women: a meta-analysis. Oxidative Medicine and Cellular Longevity, 2022. [Crossref]  [PubMed]
5. Young MJ, Wu YH, Chiu WT, Weng TY, Huang YF, Chou CY. All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells. Carcinogenesis 2015; 36:498-507 [Crossref]  [PubMed]
6. Wierzbowska N, Olszowski T, Chlubek D, Kozłowski M, Cymbaluk-Płoska A. Vitamins in Gynecologic Malignan- cies. Nutrients. 2024;16(9):1392. [Crossref]  [PubMed]
7. Bono MR, Tejon G, Flores-Santibañez F, Fernandez D, Rosemblatt M, Sauma D. Retinoic Acid as a Modulator of T Cell Immunity. Nutrients. 2016; 8(6):349. [Crossref]  [PubMed]
8. Recchia F, Saggio G, Cesta A, Candeloro G, Nuzzo A, Lombardo M, et al. Interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced ovarian cancer. Int. J. Oncol. 2005; 27:1039-1046. [Crossref]  [PubMed]
9. Zhang X, Dai B, Zhang B, Wang Z. Vitamin A, and risk of cervical cancer: A meta-analysis. Gynecol. Oncol. 2012; 124:366-373 [Crossref]  [PubMed]
10. Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary Intakes of Selected Nutrients and Food Groups and Risk of Cervical Cancer. Nutr. Cancer 2008; 60:331-341 [Crossref]  [PubMed]
11. Sedjo RL, Roe DJ, Abrahamsen M, Harris RB, Craft N, Baldwin S, et al. Vitamin A, carotenoids, and risk of per- sistent oncogenic human papillomavirus infection. Can- cer Epidemiol. Biomark. Prev. 2002; 11:876-884. [PubMed]
12. Sedjo, R.L.; Papenfuss, M.R.; Craft, N.E.; Giuliano, A.R. Effect of plasma micronutrients on clearance of oncogen- ic human papillomavirus (HPV) infection (United States). Cancer Causes Control 2003; 14:319-326. [Crossref]  [PubMed]
13. Sanusi RS. Outcome of Combined Neoadjuvant Chemo- therapy and Vitamin A in Advanced Cervical Carcinoma: A Randomized Double-Blind Clinical Trial. Asian Pac J Can- cer Prev. 2019 ;20(7):2213-2218. [Crossref]  [PubMed]
14. Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp. Mol. Med. 2018; 50:1-14. [Crossref]  [PubMed]
15. Muñoz A, Grant WB. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients. 2022; 14:1448 [Crossref]  [PubMed]
16. Valdivielso, J.M.; Fernandez, E. Vitamin D receptor poly- morphisms and diseases. Clin. Chim. Acta Int. J. Clin. Chem. 2006; 371:1-12 [Crossref]  [PubMed]
17. McCullough ML, Bandera EV, Moore DF, Kushi LH. Vi- tamin D and calcium intake in relation to risk of endome- trial cancer: A systematic review of the literature. Prev. Med. 2008; 46:298-302 [Crossref]  [PubMed]
18. Zeleniuch-Jacquotte A, Gallicchio L, Hartmuller V, Helzl- souer KJ, McCullough ML, et al. Circulating 25-hydroxyvi- tamin D and risk of endometrial cancer: Cohort consor- tium vitamin D pooling project of rarer cancers. Am. J. Epidemiol. 2010; 172:36-46. [PubMed]
19. Yan L, Gu Y, Luan T, Miao M, Jiang L, Liu Y, et al. Asso- ciations between serum vitamin D and the risk of female reproductive tumors: A meta-analysis with trial sequential analysis. Medicine 2018; 97, e0360. [Crossref]  [PubMed]
20. Ong JS, Cuellar-Partida G, Lu Y, Australian Ovarian Cancer S, Fasching PA, Hein A, Burghaus S, et al. Association of vitamin D levels and risk of ovarian cancer: A mendelian randomization study. Int. J. Epidemiol. 2016 45:1619- 1630. [PubMed]
21. Lappe JM, Travers-Gustafson D, Davies KM, Recher RR, Heaney RP. Vitamin D and calcium supplementation re- duces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586-91. [Crossref]  [PubMed]
22. Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013;5(10):3993-4021. [Crossref]  [PubMed]
23. Liao MQ, Gao XP, Yu XX, Zeng YF, Li SN, Naicker N,et al. Effects of dairy products, calcium and vitamin D on ovar- ian cancer risk: a meta-analysis of twenty-nine epidemio- logical studies. Br J Nutr. 2020;124(10):1001-1012. [Crossref]  [PubMed]
24. Webb PM, de Fazio A, Protani MM, Ibiebele TI, Nagle CM, Brand AH, et al. Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer. Am. J. Clin. Nutr. 2015;102:109-114 [Crossref]  [PubMed]
25. Shen Z, Zhang X, Tang J, Kasiappan R, Jinwal U, Li P, et al. The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hor- mone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells. Mol. Cell. Endocrinol. 2011;338:58- 67 [Crossref]  [PubMed]
26. Paucarmayta A, Taitz H, McGlorthan L, Casablanca Y, Maxwell GL, Darcy KM, et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovar- ian and Endometrial Cancer Cells In Vitro. Biomedicines 2020;8:73. [Crossref]  [PubMed]
27. Vahedpoor Z, Jamilian M, Bahmani F, Aghadavod E, Kara- mali M, Kashanian M, et al. Effects of long-term vitamin D supplementation on regression and metabolic status of cer- vical intraepithelial neoplasia: A randomized, double-blind, placebo-controlled trial. Horm. Cancer 2017;8:58-67 [Crossref]  [PubMed]
28. Li D, Liu Y, Kong D, Papukashvili D, Rcheulishvili N, Zhao H, et al. Vitamin D Receptor Gene Polymorphisms and the Risk of CIN2+ in Shanxi Population. Biomed. Res. Int. 2022; 2022:6875996 [Crossref]  [PubMed]
29. Gnagnarella P, Pasquali E, Serrano D, Raimondi S, Disalva- tore D, Gandini S. Vitamin D receptor polymorphism FokI and cancer risk: A comprehensive meta-analysis. Carcino- genesis 2014;35:1913-1919 [Crossref]  [PubMed]
30. Lyon P, Strippoli V, Fang B, Cimmino LB. Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease. Nutrients 2020;12:2867 [Crossref]  [PubMed]
31. Pieroth R, Paver S, Day S, Lammersfeld C. Folate and Its Impact on Cancer Risk. Curr. Nutr. Rep. 2018;7:70-84 [Crossref]  [PubMed]
32. Uccella S, Mariani A, Wang AH, Vierkant RA, Robien K, Anderson KE, et al. Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: A prospective cohort study. Ann. On- col. 2011;22:2129-2136. [Crossref]  [PubMed]
33. Wien TN, Pike E, Wisløff T, Staff A, Smeland S, Klemp M. Cancer risk with folic acid supplements: A systemat- ic review and meta-analysis. BMJ Open 2012;2:e000653. [Crossref]  [PubMed]
34. Gersekowski K, Ibiebele TI, Australian Ovarian Cancer Study Group, Doherty JA, Harris HR, Goodman MT, et al. Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case-Control Study from the Ovar- ian Cancer Association Consortium. Cancer Epidemiol. Biomarkers Prev. 2023;32:1087-1096 [Crossref]  [PubMed]
35. Arthur RS, Kirsh VA, Rohan TE. Dietary B-Vitamin Intake and Risk of Breast, Endometrial, Ovarian and Colorectal Cancer among Canadians. Nutr. Cancer. 201;71:1067-1077. [Crossref]  [PubMed]
36. Piyathilake CJ, Macaluso M, Alvarez RD, Bell WC, Heim- burger DC, Partridge EE. Lower Risk of Cervical Intraep- ithelial Neoplasia in Women with High Plasma Folate and Sufficient Vitamin B12 in the Post-Folic Acid Fortification Era. Cancer Prev. Res. 2009;2: 658-664 [Crossref]  [PubMed]
37. Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC, et al. Folate Is Associated with the Natural History of High-Risk Human Papillomaviruses. Cancer Res. 2004;64:8788-8793. [Crossref]  [PubMed]
38. Kwanbunjan K, Saengkar P, Cheeramakara C, Tangjitgamol S, Chitcharoenrung K. Vitamin B12 status of Thai women with neoplasia of the cervix uteri. Southeast Asian J. Trop. Med. Public Health 2006:37 (Suppl. S3):178-183 [PubMed]
39. Li Q, Ding L, Jing N, Liu C, Yang Z, Chen F, et al. Folate deficiency and aberrant DNA methylation and expression of FHIT gene were associated with cervical pathogenesis. On- col. Lett. 2018;15:1963-1972 [Crossref]
40. Sedjo RL, Fowler BM, Schneider A, Henning SM, Hatch K, Giuliano AR. Folate, vitamin B12, and homocysteine status. findings of no relation between human papillomavirus per- sistence and cervical dysplasia. Nutrition 2003;19:497-502. [Crossref]  [PubMed]
41. Hernandez BY, McDuffie K, Wilkens LR, Kamemoto L, Goodman MT. Diet and premalignant lesions of the cervix: Evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12. Cancer Causes Control 2003;14:859-870 [Crossref]  [PubMed]
42. Majumder D, Nath P, Debnath R, Maiti D. Understanding the complicated relationship between antioxidants and car- cinogenesis. J. Biochem. Mol. Toxicol. 2021; 35: e22643 [Crossref]  [PubMed]
43. Bandera EV, Gifkins DM, Moore DF, McCullough ML, Kushi LH. Antioxidant vitamins and the risk of endome- trial cancer: A dose-response meta-analysis. Cancer Caus- es Control. 2009;20:699-711 [Crossref]  [PubMed]
44. Gu JH, Gong TT, Wu QJ, Liu FH, Wen ZY, et al. Associ- ation Between Pre-diagnostic Dietary Supplements Intake and Ovarian Cancer Survival: Findings From a Prospec- tive Cohort Study in Chinese Women. Front. Nutr. 2021; 8:758178 [Crossref]  [PubMed]
45. Barchitta M, Maugeri A, La Mastra C, Rosa MC, Favara G, Lio RMS, et al. Dietary Antioxidant Intake and Human Papillomavirus Infection: Evidence from a Cross-Sectional Study in Italy. Nutrients 2020;12:1384 [Crossref]  [PubMed]
46. Cao D, Shen K, Li Z, Xu Y, Wu D. Association between vitamin C Intake and the risk of cervical neoplasia: A me- ta-analysis. Nutr. Cancer 2016; 68:48-57 [Crossref]  [PubMed]
47. Hu X, Li S, Zhou L, Zhao M, Zhu X. Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-anal- ysis of case-control studies. PLoS ONE 2017;12: e0183395 [Crossref]  [PubMed]
48. Didier AJ, Stiene J, Fang L, Watkins D, Dworkin LD, Creeden JF. Antioxidant and Anti-Tumor Effects of Dietary Vitamins A, C, and E. Antioxidants 2023;12:632. [Crossref]  [PubMed]
49. Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitiv- ity of ovarian cancer and reduced toxicity of chemotherapy. Sci. Transl. Med. 2014; 6:222ra18 [Crossref]
50. Shibayama-Imazu T, Aiuchi T, Nakaya K. Vitamin K2-Me- diated Apoptosis in Cancer Cells: Role of Mitochondrial Transmembrane Potential. In Vitamins & Hormones; El- sevier: Amsterdam, The Netherlands, 2008; pp211-266 [Crossref]  [PubMed]
51. Jiang Y, Xu S, Lan J, Zhang J, Chen T. Dietary Vitamin K Intake and HPV-Infection Status Among American Women: A Secondary Analysis from National Health and Nutrition Examination Survey Data from 2003 to 2016. Int. J. Pub- lic Health 2022; 67:1604616 [Crossref]  [PubMed]
52. Wang Z, Yang A, Yang J, Zhao W, Wang Z, et al. Dietary nutrient intake related to higher grade cervical intraepi- thelial neoplasia risk: A Chinese population-based study. Nutr. Metab. 2020;17:100. [Crossref]  [PubMed]
53. Zhu G, Li Z, Tang L, Shen M, Zhou Z, Wei Y, et al. Associa- tions of Dietary Intakes with Gynecological Cancers: Find- ings from a Cross-Sectional Study. Nutrients 2022;14:5026 [Crossref]  [PubMed]  [PMC]
54. Conforti RA, Delsouc MB, Zorychta E, Telleria CM, Ca- sais M. Copper in Gynecological Diseases. Int J Mol Sci. 2023;24(24):17578. [Crossref]  [PubMed]  [PMC]
55. Nayak SB, Bhat VR, Mayya SS. Serum Copper, Ceru- loplasmin and Thiobarbituric Acid Reactive Substance Status in Patients with Ovarian Cancer. Indian J. Physiol. Pharmacol. 2004;48:486-488. [PubMed]
56. Lin S, Yang H. Ovarian Cancer Risk According to Circulat- ing Zinc and Copper Concentrations: A Meta-Analysis and Mendelian Randomization Study. Clin. Nutr. 2021;40:2464- 2468 [Crossref]  [PubMed]
57. Zhao S, Zhang X, Gao F, Chi H, Zhang J, Xia Z, et al. Identification of Copper Metabolism-Related Subtypes and Establishment of the Prognostic Model in Ovarian Cancer. Front. Endocrinol. 2023, 14, 1145797 [Crossref]  [PubMed]  [PMC]
58. Zhang M, Shi M, Zhao Y. Association between Serum Cop- per Levels and Cervical Cancer Risk: A Meta-Analysis. Biosci. Rep. 2018; 38:BSR20180161 [Crossref]  [PubMed]  [PMC]
59. Bahamondes L, Bahamondes MV, Shulman LP. Non-Con- traceptive Benefits of Hormonal and Intrauterine Re- versible Contraceptive Methods. Hum. Reprod. Up- date 2015;21:640-651 [Crossref]  [PubMed]
60. Ermak G, Davies KJ. Calcium and oxidative stress: From cell signaling to cell death. Mol. Immunol. 2002;38:713- 721 [Crossref]  [PubMed]
61. Zemel MB, Sun, X. Dietary Calcium and Dairy Products Modulate Oxidative and Inflammatory Stress in Mice and Humans. J. Nutr. 2008;138:1047-1052 [Crossref]  [PubMed]
62. Itoh M, Oh-Ishi S, Hatao H, Leeuwenburgh C, Selman C, Ohno H, et al. Effects of dietary calcium restriction and acute exercise on the antioxidant enzyme system and oxida- tive stress in rat diaphragm. Am. J. Physiol. Integr. Comp. Physiol. 2004;287:R33-R38 [Crossref]  [PubMed]
63. Tsutsumi K, Iwatake H, Kuwabara D, Hyodo A, Kobayashi T, Koizuka I, et al.. Effects of Calcium on HPV16 Gene Transcription in Cultured Laryngeal Epithelial Cells. Nip- pon. Jibiinkoka Gakkai Kaiho 2000;103:727-733. [Crossref]  [PubMed]
64. Sengupta A, Mallick R, Dutta SR, Sarkar R. Serum calcium level in patients with carcinoma of the cervix in relation to menstrual status. Eur. J. Gynaecol. Oncol. 1989;10:153-155. [PubMed]
65. Hwang JH, Kim MK, Lee JK. Dietary Supplements Reduce the Risk of Cervical Intraepithelial Neoplasia. Int. J. Gyne- col. Cancer 2010;20:398-403. [Crossref]  [PubMed]
66. Liao MQ, Gao XP, Yu XX, Zeng YF, Li SN, Naicker N, et al. Effects of dairy products, calcium and vitamin D on ovarian cancer risk: a meta-analysis of twenty-nine epidemiological studies. British Journal of Nutrition. 2020;124(10):1001- 1012 [Crossref]  [PubMed]
67. Song X, Li Z, Ji X, Zhang D. Calcium Intake and the Risk of Ovarian Cancer: A Meta-Analysis. Nutrients. 2017;9(7):679. [Crossref]  [PubMed]  [PMC]
68. Huang T, Zhou J, Wang J. Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmaco- logical intervention. Int J Biol Sci. 2022;18(3):1065-1078. [Crossref]  [PubMed]  [PMC]
69. Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM. Iron and Cancer. Annu. Rev. Nutr. 2018;38:97-125 [Crossref]  [PubMed]  [PMC]
70. Ćwiertnia A, Kozłowski M, Cymbaluk-Płoska A. The Role of Iron and Cobalt in Gynecological Diseases. Cells. 2022;12(1):117. [Crossref]  [PubMed]  [PMC]
71. Basuli D, Tesfay L, Deng Z, Paul B, Yamamoto Y, Ning G, et al. Iron addiction: A novel therapeutic target in ovar- ian cancer. Oncogene 2017; 36:4089-4099 [Crossref]  [PubMed]  [PMC]
72. Terry P, Vainio H, Wolk A, Weiderpass E. Dietary factors in relation to endometrial cancer: A nationwide case-con- trol study in Sweden. Nutr. Cancer 2002;42:25-32. [Crossref]  [PubMed]
73. Yaman M, Kaya G, Simsek M. Comparison of trace el- ement concentrations in cancerous and noncancerous human endometrial and ovary tissues. Int. J. Gynecol. Cancer 2007;17:220-228 [Crossref]  [PubMed]
74. Genkinger JM, Friberg E, Goldbohm RA, Wolk A. Long- term dietary heme iron and red meat intake in relation to en- dometrial cancer risk. Am. J. Clin. Nutr. 2012;96:848-854 [Crossref]  [PubMed]
75. Kabat GC, Miller AB, Jain M, Rohan TE. Dietary iron and haem iron intake and risk of endometrial cancer: A prospec- tive cohort study. Br. J. Cancer 2008;98:194-198 [Crossref]  [PubMed]  [PMC]
76. Ito H, Takagi Y, Ando Y, Kubo A, Hashimoto S, Tsutsui F, et al. Serum Ferritin Levels in Patients with Cervical Cancer. Obstet. Gynecol. 1980;55:358-362 [Crossref]  [PubMed]
77. Labunskyy VM, Hatfield DL, Gladyshev VN. Selenopro- teins: Molecular Pathways and Physiological Roles. Physi-ol. Rev. 2014;94:739-777. [Crossref]  [PubMed]  [PMC]
78. Cunzhi, H.; Jiexian, J.; Xianwen, Z.; Jingang, G.; Shumin, Z.; Lili, D. Serum and Tissue Levels of Six Trace Elements and Copper/Zinc Ratio in Patients with Cervical Cancer and Uterine Myoma. Biol. Trace Elem. Res. 2003, 94, 113-122 [Crossref]  [PubMed]
79. Kim SJ, Choi MC, Park JM, Chung AS. Antitumor Effects of Selenium. Int J Mol Sci. 2021;22(21):11844. [Crossref]  [PubMed]  [PMC]
80. Lee KH, Jeong D. Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: The selenium paradox (Review). Mol. Med. Rep. 2012;5:299-304 [PubMed]
81. Obhielo E, Ezeanochie M, Olokor O, Okonkwo A, Gharoro E. The Relationship between the Serum Level of Seleni- um and Cervical Intraepithelial Neoplasia: A Comparative Study in a Population of Nigerian Women. Asian Pacific J. Cancer Prev. 2019;20:1433-1436. [Crossref]  [PubMed]  [PMC]
82. He D, Wang Z, Huang C, Fang X, Chen D. Serum Selenium Levels and Cervical Cancer: Systematic Review and Meta- Analysis. Biol. Trace Elem. Res. 2017;179:195-202 [Crossref]  [PubMed]
83. Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM. Iron and Cancer. Annu. Rev. Nutr. 2018;38: 97-125. [Crossref]  [PubMed]  [PMC]
84. Karamali M, Nourgostar S, Zamani A, Vahedpoor Z, Ase- mi Z. The favourable effects of long-term selenium supple- mentation on regression of cervical tissues and metabolic profiles of patients with cervical intraepithelial neoplasia: A randomised, double-blind, placebo-controlled trial. Br. J. Nutr. 2015;114: 2039-2045. [Crossref]  [PubMed]
85. Muecke R, Schomburg L, Glatzel M, Berndt-Skorka R, Baaske D, Reichl B, et al. Multicenter, phase 3 trial com- paring selenium supplementation with observation in gy- necologic radiation oncology. Int. J. Radiat. Oncol. Biol. Phys. 2010; 78:828-835 [Crossref]  [PubMed]
86. Kho PF, Glubb DM, Thompson DJ, Spurdle AB, O'Mara TA. Assessing the role of selenium in endometrial can- cer risk: A mendelian randomization study. Front. Oncol. 2019;9:182 [Crossref]  [PubMed]  [PMC]
87. Sieja K, Talerczyk M. Selenium as an element in the treat- ment of ovarian cancer in women receiving chemotherapy. Gynecol. Oncol. 2004; 93:320-327. [Crossref]  [PubMed]
88. Golara A, Kozłowski M, Guzik P, Kwiatkowski S, Cymba- luk-Płoska A. The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endome- trial and Ovarian Cancer. International Journal of Molecular Sciences. 2023; 24(13):10887 [Crossref]  [PubMed]  [PMC]
89. Chasapi CT, Loutsidou AC, Spiliopoulou CA, Ste- fanidou M. Zinc and human health: An update. Arch. Toxicol. 2012;86:521-534. [Crossref]  [PubMed]
90. Michalczyk K, Cymbaluk-Płoska A. The Role of Zinc and Copper in Gynecological Malignancies. Nutri- ents. 2020;12(12):3732 [Crossref]  [PubMed]  [PMC]
91. Velthuis AJWT, Worm SHEVD, Sims AC, Baric RS, Sni- jder EJ, Van Hemert MJ. Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture. PLoS Pathog. 2010;6:e1001176 [Crossref]  [PubMed]  [PMC]
92. Xie Y, Wang J, Zhao X, Zhou X, Nie X, Li C, et al. Higher serum zinc levels may reduce the risk of cervi- cal cancer in Asian women: A meta-analysis. J. Int. Med. Res. 2018;46:4898-4906 [Crossref]  [PubMed]  [PMC]
93. Atakul T, Altinkaya O, Abas BI, Yenisey C. Serum Copper and Zinc Levels in Patients with Endometrial Cancer. Biol. Trace Elem. Res. 2019;195:46-54. [Crossref]  [PubMed]
94. Lin S, Yang H. Ovarian cancer risk according to circulating zinc and copper concentrations: A meta-analysis and Men- delian randomization study. Clin Nutr. 2021;40(4):2464- 2468 [Crossref]  [PubMed]